Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |